CRT 2025

Late-Breaking Clinical Trials Endovascular

Large-Bore Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism in Patients with Contraindications to Thrombolytics | Outcomes from the Non-Randomized PEERLESS Cohort

Speaker(s)

• 

  Stefan Stortecky, MD

  Swiss Cardiovascular Center Bern
  Bern, Bern, Switzerland

  Disclosure information not submitted.